Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7725–7729. doi: 10.1073/pnas.84.21.7725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Handa K., Kono S., Saku K., Sasaki J., Kawano T., Sasaki Y., Hiroki T., Arakawa K. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis. 1989 Jun;77(2-3):209–213. doi: 10.1016/0021-9150(89)90083-x. [DOI] [PubMed] [Google Scholar]
- Jay R. H., McCarthy S. N., Rampling M. W., Betteridge D. J. Blood rheology and fibrinogen in children with familial hypercholesterolaemia. Atherosclerosis. 1991 Nov;91(1-2):117–121. doi: 10.1016/0021-9150(91)90193-7. [DOI] [PubMed] [Google Scholar]
- Jay R. H., Rampling M. W., Betteridge D. J. Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment. Atherosclerosis. 1990 Dec;85(2-3):249–256. doi: 10.1016/0021-9150(90)90117-2. [DOI] [PubMed] [Google Scholar]
- Machin S. J., Mackie I. J. Routine measurement of fibrinogen concentration. BMJ. 1993 Oct 9;307(6909):882–883. doi: 10.1136/bmj.307.6909.882. [DOI] [PMC free article] [PubMed] [Google Scholar]